View All Patents
EP4512389
Unitary patentDEGARELIX DRUG PRODUCT
Filed
May 31, 2013
Technology
Chemistry · Pharmaceuticals
UPC cases
1
EPO proceedings
1
Ownership history
As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.
- FERRING B.V.since Jan 24, 2025
Abstract
The present invention provides methods for producing a lyophilized degarelix product which, upon reconstitution with water for injection in an amount of 20 mg/ml, shows a viscosity of up to 15 mPas.The present invention also provides a lyophilized degarelix drug substance which shows, upon dissolution in water in an amount of 20 mg/ml, a viscosity of up to 3.2 mPas, and processes for providing this lyophilized degarelix drug substance.
Litigation history
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Jun 9, 2026 | UPC CFI 1470/2026 | The Hague LD | Infringement | Locked | FERRING B.V. +11 |
Additional proceedings on this patent
Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in